Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
How We Treat Myeloproliferative NeoplasmsClaire N Harrison, Donal P McLornan, Yvonne A Francis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.
British Journal of Haematology|August 9, 2025
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Timo Brand, et al.
British Journal of Haematology|May 16, 2019
Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experienceJoana Desterro, Donal P McLornan, Natalia Curto Garcia, et al.
Hemasphere|June 28, 2021
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021Jamie Saunders, Natalia Curto-Garcia, Priya Sriskandarajah, et al.
Blood Advances|May 31, 2022
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosisAndreas Reiter, Juliana Schwaab, Daniel J DeAngelo, et al.
Haematologica|September 25, 2025
Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinibJasmine Makker, Kyaw Htin Thaw, Amna Sheikh, et al.
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Leukemia Research|July 25, 2025
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control studyAndreas Reiter, Jason Gotlib, Iván Álvarez-Twose, et al.
Nature Medicine|December 7, 2021
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trialDaniel J DeAngelo, Deepti H Radia, Tracy I George, et al.
Pageof 4